Samuele Doratori

Samuele Doratori has extensive experience in global product strategy, particularly in neurology and cardio-metabolic diseases, with a proven track record at Servier from September 2022 to May 2025 overseeing a $3 billion portfolio involving cross-department management, global marketing, and business performance. Prior to this role, Samuele worked at MENARINI Group from April 2006 to May 2013 in various capacities including medical/marketing in respiratory, allergology, and cardiovascular sectors, alongside sales experience. Samuele is further enhancing expertise through executive education in Behavioral Science and Persuasion at Stanford University Graduate School of Business, and ongoing studies at HMX – Harvard Medical School.